Filtricine

Developer of therapies for treating cancer based on nutrient deprivation

placeSunnyvale, California, United States calendar_todayFounded 2017 groups5 employees language filtricine.com

Registered entities

Innovation

3 patent families (1 granted) — focus: Human necessities, Electricity & electronics; filing pace slowing. Cited 136 times.

YearFilings
20191
20201
20212
20222
20232
20241

Investor mix

8 investors on record; lead investors include Boutique Venture Partners, Berkeley Catalyst Fund.

Investor typeCountShare
Venture capital675%
Angel & family office113%
Accelerator & incubator113%
Coming soon